Revenue
No reported data
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Research & development | ¥243.9M | ¥210.4M | ¥195.7M | — | — | — | — |
| Operating expenses | — | — | — | — | ¥8.70B | ¥5.35B | ¥4.69B |
| Operating income | ¥456.2M | ¥29.0M | −¥173.3M | −¥2.62B | −¥895.1M | −¥458.8M | −¥731.8M |
| EBITDAderived | ¥572.5M | ¥296.0M | ¥160.4M | −¥2.22B | −¥521.3M | −¥98.0M | −¥497.1M |
| Net income | ¥336.3M | −¥8.2M | −¥156.3M | −¥2.47B | −¥816.5M | −¥470.6M | −¥704.9M |
| Basic EPSper diluted share | CN¥2.08 | -CN¥0.05 | -CN¥0.96 | -CN¥15.16 | -CN¥13.76 | -CN¥94.51 | -CN¥84.27 |
| Diluted EPSper diluted share | CN¥2.07 | -CN¥0.05 | -CN¥0.96 | -CN¥15.16 | -CN¥13.76 | -CN¥94.51 | -CN¥84.27 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026Form 4 | Zhu RuiDirector | SellAmerican depositary shares | 4.8K | $4.00 | $19.0K | 55.2K |